While BRAC1/2 mutation is a risk factor for breast cancer, lower serum OPG levels were correlated with the germline mutations of BRAC1/2 known to facilitate breast cancer risk [66]. The gene discussed is TNFRSF11B; the disease is breast carcinoma.